Literature DB >> 34638123

Candida Pneumonia: An Innocent Bystander or a Silent Killer?

Durga Shankar Meena1, Deepak Kumar1.   

Abstract

Invasive candidiasis is predominantly seen in immunosuppressed patients and carries a significant mortality. The clinical spectrum of invasive candidiasis encompasses candidemia and disseminated infection (intra-abdominal abscess, osteomyelitis, endophthalmitis, and Candida meningitis). The existence of Candida pneumonia has been largely debated over the years due to its rarity and presence of frequent colonization. Demonstration of Candida species by lung biopsy along with evidence of inflammation is the only way to confirm this entity. The interpretation of Candida in respiratory specimens and the decision to initiate antifungal therapy is controversial due to the lack of clinical evidence. In this mini-review, we discuss the currently available clinical data from the literature on Candida pneumonia and future perspectives regarding the need for antifungal therapy in such patients.
© 2021 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Antifungal treatment; Beta-D-glucan; Candida; Colonization; Pneumonia

Mesh:

Substances:

Year:  2021        PMID: 34638123      PMCID: PMC8995637          DOI: 10.1159/000520111

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  29 in total

1.  Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study.

Authors:  M el-Ebiary; A Torres; N Fàbregas; J P de la Bellacasa; J González; J Ramirez; D del Baño; C Hernández; M T Jiménez de Anta
Journal:  Am J Respir Crit Care Med       Date:  1997-08       Impact factor: 21.405

2.  Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study.

Authors:  W Meersseman; K Lagrou; I Spriet; J Maertens; E Verbeken; W E Peetermans; E Van Wijngaerden
Journal:  Intensive Care Med       Date:  2009-04-09       Impact factor: 17.440

Review 3.  Nonmolecular methods for the diagnosis of respiratory fungal infections.

Authors:  Frédéric Lamoth; Barbara D Alexander
Journal:  Clin Lab Med       Date:  2014-04-12       Impact factor: 1.935

Review 4.  The significance of Candida in the human respiratory tract: our evolving understanding.

Authors:  Kathryn M Pendleton; Gary B Huffnagle; Robert P Dickson
Journal:  Pathog Dis       Date:  2017-04-01       Impact factor: 3.166

5.  Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study).

Authors:  Martin Albert; David Williamson; John Muscedere; Francois Lauzier; Coleman Rotstein; Salmaan Kanji; Xuran Jiang; Mark Hall; Daren Heyland
Journal:  Intensive Care Med       Date:  2014-07-01       Impact factor: 17.440

6.  Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail.

Authors:  Damien Roux; Stéphane Gaudry; Linda Khoy-Ear; Meryem Aloulou; Mathilde Phillips-Houlbracq; Julie Bex; David Skurnik; Erick Denamur; Renato C Monteiro; Didier Dreyfuss; Jean-Damien Ricard
Journal:  Crit Care Med       Date:  2013-09       Impact factor: 7.598

Review 7.  Emerging fungal diseases.

Authors:  Marcio Nucci; Kieren A Marr
Journal:  Clin Infect Dis       Date:  2005-07-11       Impact factor: 9.079

Review 8.  Candida albicans interactions with bacteria in the context of human health and disease.

Authors:  Diana K Morales; Deborah A Hogan
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

9.  Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model.

Authors:  Florence Ader; Samir Jawhara; Saad Nseir; Eric Kipnis; Karine Faure; Fanny Vuotto; Chanez Chemani; Boualem Sendid; Daniel Poulain; Benoit Guery
Journal:  Crit Care       Date:  2011-06-20       Impact factor: 9.097

10.  Candida species in community-acquired pneumonia in patients with chronic aspiration.

Authors:  Benjamin J Moss; Daniel M Musher
Journal:  Pneumonia (Nathan)       Date:  2021-07-05
View more
  4 in total

1.  COVID-19-associated fungal infections in Iran: A systematic review.

Authors:  Tina Nazari; Fatemeh Sadeghi; Alireza Izadi; Setayesh Sameni; Shahram Mahmoudi
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

Review 2.  Essential Oils in Respiratory Mycosis: A Review.

Authors:  Mónica Zuzarte; Lígia Salgueiro
Journal:  Molecules       Date:  2022-06-28       Impact factor: 4.927

Review 3.  Microbiologically confirmed infections and antibiotic-resistance in a national surveillance study of hospitalised patients who died with COVID-19, Italy 2020-2021.

Authors:  Marco Floridia; Marina Giuliano; Monica Monaco; Luigi Palmieri; Cinzia Lo Noce; Anna Teresa Palamara; Annalisa Pantosti; Silvio Brusaferro; Graziano Onder
Journal:  Antimicrob Resist Infect Control       Date:  2022-05-21       Impact factor: 6.454

4.  Change for the Better: Severe Pneumonia at the Emergency Department.

Authors:  Dariusz Kawecki; Anna Majewska; Jarosław Czerwinski
Journal:  Pathogens       Date:  2022-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.